3rd Quarter - Report

NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION

Firm
Client
Income
—
Expenses
$56,333
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Labor HHS Appropriations: appropriations levels for NIH, NCI, CDC and AHRQ Agriculture Appropriations: appropriations level for FDA

LobbyistCovered position, as disclosed
EMILY BROWN —
NANCY DAVENPORT-ENNIS —
JIM GOTTLIEB —
AMY WOTRING —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare reimbursement, social security disability

LobbyistCovered position, as disclosed
EMILY BROWN —
NANCY DAVENPORT-ENNIS —
JIM GOTTLIEB —
AMY WOTRING —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Health Issues HCR

Pre-existing condition legislation, prescription drug reimbursement, health information technology, medical imaging, low-income subsidy under Medicare, FDA regulation of tobacco, clinical trials, health care reform, patient safety and quality improvement, positron emission tomography (PET), hospital inpatient prospective payment system

LobbyistCovered position, as disclosed
EMILY BROWN —
NANCY DAVENPORT-ENNIS —
JIM GOTTLIEB —
AMY WOTRING —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.